SE425489B - Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner - Google Patents

Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner

Info

Publication number
SE425489B
SE425489B SE7509640A SE7509640A SE425489B SE 425489 B SE425489 B SE 425489B SE 7509640 A SE7509640 A SE 7509640A SE 7509640 A SE7509640 A SE 7509640A SE 425489 B SE425489 B SE 425489B
Authority
SE
Sweden
Prior art keywords
trisubstituted
piperidines
phenyl
preparation
analogy procedure
Prior art date
Application number
SE7509640A
Other languages
English (en)
Swedish (sv)
Other versions
SE7509640L (sv
Inventor
D M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7509640L publication Critical patent/SE7509640L/xx
Publication of SE425489B publication Critical patent/SE425489B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7509640A 1974-09-06 1975-08-29 Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner SE425489B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50358174A 1974-09-06 1974-09-06

Publications (2)

Publication Number Publication Date
SE7509640L SE7509640L (sv) 1976-03-08
SE425489B true SE425489B (sv) 1982-10-04

Family

ID=24002675

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7509640A SE425489B (sv) 1974-09-06 1975-08-29 Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner

Country Status (27)

Country Link
US (1) US4081450A (xx)
JP (3) JPS5929588B2 (xx)
AR (1) AR206937A1 (xx)
AT (1) AT350567B (xx)
BE (1) BE833044A (xx)
BG (2) BG24802A3 (xx)
CA (1) CA1069901A (xx)
CH (1) CH625787A5 (xx)
CS (1) CS188237B2 (xx)
DD (1) DD121636A5 (xx)
DE (1) DE2539452A1 (xx)
DK (1) DK153397C (xx)
ES (1) ES440771A1 (xx)
FR (2) FR2283679A1 (xx)
GB (1) GB1525584A (xx)
HU (1) HU173057B (xx)
IE (1) IE41610B1 (xx)
IL (1) IL48003A (xx)
NL (1) NL7510535A (xx)
NZ (1) NZ178501A (xx)
PH (2) PH12618A (xx)
PL (3) PL100438B1 (xx)
RO (1) RO68142A (xx)
SE (1) SE425489B (xx)
SU (2) SU629875A3 (xx)
YU (2) YU221675A (xx)
ZA (1) ZA755614B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
FR2451368A1 (fr) * 1979-03-12 1980-10-10 Lilly Co Eli Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
ZA813127B (en) * 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
FR2518093A2 (fr) * 1980-12-15 1983-06-17 Roussel Uclaf Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4931558A (en) * 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
US4678638A (en) * 1985-07-24 1987-07-07 Petrolite Corporation Highly branched amino hexahydropyridines
ES2058265T3 (es) * 1987-04-16 1994-11-01 Lilly Co Eli Piperidinas antagonistas de opiaceos.
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof
BR112016000844A8 (pt) * 2013-07-15 2020-01-07 Coral Sunscreen Pty Ltd compostos absorvedores de uv, composições que compreendem os mesmos, usos destes e método de proteger uma superfície ou tecido dos raios uv

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD87036A (xx) *
US2892842A (en) * 1959-06-30 Their preparation
US1915334A (en) * 1930-10-16 1933-06-27 Du Pont Fluosilicate of organic heterocyclic bases and process of making it
US2075359A (en) * 1930-10-16 1937-03-30 Du Pont Insecticide
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives

Also Published As

Publication number Publication date
YU221675A (en) 1982-02-28
DD121636A5 (xx) 1976-08-12
YU233681A (en) 1982-02-28
ES440771A1 (es) 1977-04-01
IL48003A0 (en) 1975-11-25
GB1525584A (en) 1978-09-20
IE41610L (en) 1976-03-06
HU173057B (hu) 1979-02-28
JPS6026782B2 (ja) 1985-06-25
DK153397C (da) 1988-12-05
FR2299337B1 (xx) 1979-01-19
FR2299337A1 (fr) 1976-08-27
BG24802A3 (en) 1978-05-12
AT350567B (de) 1979-06-11
CH625787A5 (xx) 1981-10-15
BE833044A (fr) 1976-03-03
PL100438B1 (pl) 1978-10-31
PH12618A (en) 1979-07-05
SU621316A3 (ru) 1978-08-25
AR206937A1 (es) 1976-08-31
US4081450A (en) 1978-03-28
JPS5148670A (xx) 1976-04-26
NL7510535A (nl) 1976-03-09
NZ178501A (en) 1978-09-20
BG24950A3 (en) 1978-06-15
JPS5916875A (ja) 1984-01-28
JPS5929588B2 (ja) 1984-07-21
PH14016A (en) 1980-12-08
JPS6051174A (ja) 1985-03-22
DK397575A (da) 1976-03-07
PL108465B1 (en) 1980-04-30
ATA685275A (de) 1978-11-15
RO68142A (ro) 1981-08-30
SU629875A3 (ru) 1978-10-25
DK153397B (da) 1988-07-11
ZA755614B (en) 1977-04-27
IL48003A (en) 1981-01-30
CA1069901A (en) 1980-01-15
FR2283679A1 (fr) 1976-04-02
DE2539452A1 (de) 1976-03-18
IE41610B1 (en) 1980-02-13
JPS6012350B2 (ja) 1985-04-01
CS188237B2 (en) 1979-02-28
AU8431375A (en) 1977-03-03
FR2283679B1 (xx) 1979-09-14
PL117501B1 (en) 1981-08-31
SE7509640L (sv) 1976-03-08

Similar Documents

Publication Publication Date Title
SE425489B (sv) Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner
NO142401C (no) Analogifremgangsmaate til fremstilling av mavesyresekresjonshemmende 2-pyridylalkyltiobenzimidazoler
SE7513085L (sv) Forfarande for framstellning av etrar
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE425660B (sv) Analogiforfarande for framstellning av 1,4-dihydropyridiner
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
SE424638B (sv) Analogiforfarande for framstellning av 5,7-dihydroxi-tetrahydroisokinolin derivat
SE7513879L (sv) Forfarande for syntes av karbamider
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE427927B (sv) Analogiforfarande for framstellning av symmetriska metylsubstituerade 3,14-ditia-1,16-hexadekandioler
SE423992B (sv) Forfarande for framstellning av 9, 11, 15-trihydroxi-13, 14-dehydroprostaglandiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7509640-4

Effective date: 19910315

Format of ref document f/p: F